Drugs / Bacille Calmette-Guérin
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04922047 Background | Jun → Dec 2021 | urinary bladder neoplasm | RenJi Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bacille Calmette-Guérin | “Bacille Calmette-Guérin (BCG)” NCT04922047 ↗ |
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04922047 ↗ |